Contract with CKD expected to boost domestic sales

March 1, 2017

 

BioPlus Co., Ltd. and Chong Kun Dang Pharma, one of the biggest pharmaceutical companies in Korea with a capital of 20 million USD, signed an exclusive distributorship contract on February 10, 2017 for the distribution of BioPlus Co., Ltd.'s SkinPLus-HYAL and HyalDew products in the region of Korea . The products are planned to be launched on April.

 

BioPlus Co., Ltd. products are already recognized as a long lasting product with a high quality standard. Chong Kun Dang Pharma's brand image and their sales ability in conjunction with the quality and standard of BioPlus Co., Ltd., products will create a synergy to boost sales for both companies.

Please reload

BioPlus

Leader in HA filler manufacturing